logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Clutterbuck, Matthew Simon
    Director born in September 1963
    Individual (2 offsprings)
    Officer
    icon of calendar 2011-04-28 ~ dissolved
    OF - Director → CIF 0
    Mr Matthew Simon Clutterbuck
    Born in September 1963
    Individual (2 offsprings)
    Person with significant control
    icon of calendar 2017-04-28 ~ dissolved
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

PARTNERS CLINICAL LIMITED

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Average Number of Employees
12022-04-01 ~ 2023-03-31
12021-04-01 ~ 2022-03-31
Property, Plant & Equipment
420 GBP2023-03-31
560 GBP2022-03-31
Debtors
936 GBP2023-03-31
17,179 GBP2022-03-31
Cash at bank and in hand
23,955 GBP2023-03-31
34,375 GBP2022-03-31
Current Assets
24,891 GBP2023-03-31
51,554 GBP2022-03-31
Creditors
Amounts falling due within one year
1,849 GBP2023-03-31
13,915 GBP2022-03-31
Net Current Assets/Liabilities
23,042 GBP2023-03-31
37,639 GBP2022-03-31
Total Assets Less Current Liabilities
23,462 GBP2023-03-31
38,199 GBP2022-03-31
Net Assets/Liabilities
23,462 GBP2023-03-31
38,199 GBP2022-03-31
Equity
Called up share capital
1 GBP2023-03-31
1 GBP2022-03-31
Retained earnings (accumulated losses)
23,461 GBP2023-03-31
38,198 GBP2022-03-31
Equity
23,462 GBP2023-03-31
38,199 GBP2022-03-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-308 GBP2022-04-01 ~ 2023-03-31
308 GBP2021-04-01 ~ 2022-03-31
Profit/Loss on Ordinary Activities Before Tax
-8,045 GBP2022-04-01 ~ 2023-03-31
2,170 GBP2021-04-01 ~ 2022-03-31
Tax Expense/Credit at Applicable Tax Rate
-1,529 GBP2022-04-01 ~ 2023-03-31
412 GBP2021-04-01 ~ 2022-03-31
Property, Plant & Equipment - Gross Cost
2,316 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,896 GBP2023-03-31
1,756 GBP2022-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
140 GBP2022-04-01 ~ 2023-03-31
Trade Debtors/Trade Receivables
17,179 GBP2022-03-31
Other Debtors
936 GBP2023-03-31
Trade Creditors/Trade Payables
Amounts falling due within one year
3,616 GBP2022-03-31
Corporation Tax Payable
Amounts falling due within one year
308 GBP2022-03-31
Other Taxation & Social Security Payable
Amounts falling due within one year
2,122 GBP2022-03-31
Other Creditors
Amounts falling due within one year
1,849 GBP2023-03-31
7,869 GBP2022-03-31

  • PARTNERS CLINICAL LIMITED
    Info
    Registered number 07617133
    icon of addressZone G, Salamander Quay West, Harefield, Middlesex UB9 6NZ
    PRIVATE LIMITED COMPANY incorporated on 2011-04-28 and dissolved on 2024-09-03 (13 years 4 months). The company status is Dissolved.
    The last date of confirmation statement was made at 2023-04-28
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.